• 비만대사연구학술지
• /
• 제1권2호
• /
• pp.47-52
• /
• 2022

Digital therapeutics (DTx) are emerging as a novel solution to improve lifestyle and prevent non-communicable diseases. Obesity is a complex, multi-factorial, chronic condition that requires patient-centered lifestyle modification. DTx, such as mobile applications and wearables, may offer easily accessible, efficient, and personalized care in the field of obesity and metabolic diseases. Yet, there is controversy over its clinical usefulness. This review will provide a comprehensive overview of DTx, including its potential role and current limitation in obesity care, based on recent literature.

• 전자통신동향분석
• /
• 제39권4호
• /
• pp.73-81
• /
• 2024

As the demand for a healthy life increases and the use of information technology expands, interest in digital healthcare has increased. Among the digital healthcare technologies, digital therapeutics (DTx), which are capable of disease prevention, management, and treatment rather than simple healthcare, are expected to play a key role in future healthcare services. As interest in untact remote treatment that can minimize the risk of viral infection has rapidly increased since the spread of COVID-19, the application of DTx has received much attention because it can partially replace face-to-face treatment for mental illnesses, chronic diseases, and other diseases, reducing concerns about infection. In addition, because of the nature of software, DTx have lower toxicity and fewer side effects than existing treatments and do not require manufacturing, transportation, and storage like general medicines. Hence, they can be supplied in large quantities at low cost and have the advantage of lowering medical costs. However, despite these advantages, it has been pointed out that there are difficulties in investment and universal use because of the complexity of pricing and malpractice compensation. In other words, if it is difficult to prove and measure the improvements in disease management and treatment using DTx and it takes a considerable amount of time and money to do so, it will be difficult to attract investment from stakeholders such as medical providers and pharmaceutical companies. In this paper, we examine the domestic and global application status and development trends of DTx and determine the relevant implications.

• Korean Circulation Journal
• /
• 제52권4호
• /
• pp.265-279
• /
• 2022

Digital health is rapidly growing worldwide and its area is expanding from wellness to treatment due to digital therapeutics (DTx). This study compared DTx in the Korean context with other countries to better understand its political and practical implications. DTx is generally the same internationally, often categorized as software as a medical device. It provides evidence-based therapeutic interventions for medical disabilities and diseases. Abroad, DTx support entailed state subsidies and fundraising and national health insurance coverage. In the case of national health insurance coverage, most cases were applied to mental diseases. Moreover, in Japan, DTx related to hypertension will possibly be under discussion for national health insurance coverage in 2022. In overseas countries, coverage was decided only when the clinical effects were equivalent to those provided by existing technology, and in the UK, real usage data for DTx and associated evaluations were reflected by national health coverage determination. Prices were either determined through closed negotiations with health insurance operating agencies and manufacturers or established based on existing technology. Concerning the current situation, DTx dealing with various diseases including hypertension are expected to be developed near in the future, and the demand for use and compensation will likely increase. Therefore, it is urgent to define and prepare for DTx, relevant support systems, and health insurance coverage listings. Several support systems must be considered, including government subsidies, science/technology funds, and health insurance.

• 인터넷정보학회논문지
• /
• 제24권4호
• /
• pp.15-24
• /
• 2023

Digital therapeutics (DTx) are utilized to replace or supplement drug therapy to treat patients. DTx are developed as a mobile application for portability and convenience. The government requires security verification to be performed on digital medical devices that manage sensitive information during the transmission and storage of patient data. Although safety verification is included in the approval process for DTx, the cybersecurity checklist used as a reference does not reflect the characteristics of mobile applications. This poses the risk of potentially overlooking vulnerabilities during security verification. This study aims to address this issue by comparing and analyzing existing items based on the mobile tactics, techniques, and procedures of MITRE ATT&CK, which manages globally known and occurring vulnerabilities through regular updates. We identify 16 items that require improvement and expand the checklist to 29 items to propose improvement measures. The findings of this study may contribute to the safe development and advancement of DTx for managing sensitive patient information.

• 인터넷정보학회논문지
• /
• 제25권3호
• /
• pp.9-18
• /
• 2024

Digital therapy has emerged as a novel treatment modality, propelled by advancements in information and communication technology. In the last five years, there has been a substantial surge in research publications addressing digital therapeutics (DTx) interventions, signaling a sustained upward trajectory in this field. The dynamic nature of computer science, marked by continuous innovation and development, underscores the need for agile adaptation to rapid changes. Consequently, computer science education is compelled to offer students insights into the latest trends. This research endeavors to contribute to the evolving landscape by developing textbooks that impart knowledge about DTx, an integration of information technology. The study focuses on the application of these textbooks to elementary and middle school students in South Korea. The instructional materials have been carefully organized to enable students to learn about the principle of Attention Deficit Hyperactivity Disorder (ADHD) DTx at the elementary level and the DTx that can prevent and address the digital drama at the middle school level. Based on the application of the textbook, students who received instruction using the textbook showed statistically significant improvements in all subcategories of creative problem-solving ability, including idea modification, visualization, task focus, analogy, idea generation, and elaboration (p<.01). Additionally, there were statistically significant changes in students' self-efficacy before and after using the textbook, with negative efficacy decreasing, and positive efficacy and social efficacy increasing (p<.001).

• 말소리와 음성과학
• /
• 제14권4호
• /
• pp.57-66
• /
• 2022

본 연구는 '디지털 치료제'의 정의를 확인하기 위해 이와 관련된 연구들을 통해 확인해보고, 디지털 치료제의 개발 동향을 국내 수준에서 조사해 보았다. 그리고 2015년 이후 연구 자료를 대상으로 디지털 치료제가 의사소통장애 분야에서 언어장애와 말장애 대상자들 중 어떤 장애 분야에 적용된 연구가 진행되어 왔는지 그리고 어떠한 기술이 적용된 연구가 이루어 왔는가 역시 분석해 보았다. 그 결과 디지털 치료제는 소프트웨어라는 점, 예방·관리·치료하기 위해 환자에게 적용되는 소프트웨어적인 치료제이며 근거 기반 치료를 제공하는 소프트웨어로 정의할 수 있다. 디지털 치료제와 관련해서 엄청난 투자를 진행하고 있고 이와 더불어 관련된 연구도 지속적으로 증가하고 있음을 확인할 수 있었다. 다음으로 의사소통장애 대상자에게 디지털 치료제를 적용한 2015년 연구 사례를 분석한 결과 언어장애에 해당하는 연구가 전체 22편 중에서 17편으로 주를 이루었고, 말장애 분야 연구, 일반아동을 대상으로 한 연구, 전문가를 대상으로 한 연구가 있었다. 디지털 치료제에 적용될 수 있는 다양한 기술 중 가장 많이 적용된 기술은 가상현실과 증강현실이었다. 가상현실보다는 증강현실을 적용한 연구가 대부분이었음을 확인할 수 있었고 AI를 적용한 연구도 있었다. 그리고 디지털 치료제의 적용 후 효과는 대부분 긍정적으로 나타났고, 디지털 치료제 개발과 관련해서 대부분은 콘텐츠 개발에 중점을 두고 있으나 한 편의 연구는 앱 개발을 위해 진행된 연구다. 향후 연구에서는 보다 다양한 의사소통장애 대상자에게 적용 가능한 소프트웨어를 개발하고 보다 광범위한 기술을 적용한 연구들이 꾸준히 이루어지고 이러한 분야에 대한 정부의 적극적인 지원도 이루어지기를 기대해 본다.

• 산업융합연구
• /
• 제21권9호
• /
• pp.23-32
• /
• 2023

게임을 통해 건강을 증진할 수 있는 건강 기능성 게임(SGHs)에 대한 관심이 고조되고 있다. 디지털 치료제(DTx)는 유효성과 안전성을 확보한 치료제이기 때문에 전통적인 의약품 유통방식을 따라야 하지만, SGHs는 웰니스 제품으로 DTx에 비해 보급과 확산이 유연하다. 또한 SGHs는 일시적인 치료 효과가 아닌 지속적인 모니터링과 피드백을 통해 맞춤형 서비스를 제공할 수 있어 효과적이며, SGHs를 인지장애치료나 행동교정 등에 적용할 경우 오작동과 부작용이 경미하다. 본 연구는 SGHs의 지각된 혜택과 위험을 동시에 고려하는 밸런스 프레임워크(Valence Framework)를 기반으로 142명의 학부생을 대상으로 설문을 수집하여 지각된 혜택만이 SGHs 사용 의도에 통계적으로 유의한 정(+)의 영향을 준다는 점을 실증하였다. 이러한 결과를 바탕으로 일반 사용자를 대상으로 한 SGHs 수용에 있어 혜택(유효성)을 중심으로 홍보하고, 데이터 주도형 (data-driven) 접근방법의 중요성과 데이터 주도형 유통 및 분석 플랫폼 전략의 필요하다는 시사점을 제시하였다.

• 정보처리학회 논문지
• /
• 제13권7호
• /
• pp.319-325
• /
• 2024

본 연구는 공황장애 케어를 위한 모바일 어플리케이션을 개발하여 공황 발작 예방 및 증상 관리를 돕는 것을 목적으로 한다. 공황장애란 지속적인 두려움과 불안, 공황발작 등의 증상을 가지는 심리적 장애로 적절한 치료 및 관리를 필요로 하는 정신질환 중 하나이다. 이에 시공간적 제약 없이 사용할 수 있는 어플리케이션을 통해 사용자가 케어를 받을 수 있는 디지털 치료제의 필요성이 증대되고 있는 추세이다. 연구를 통해 개발된 어플리케이션은 공황장애에 대한 기본적인 정보를 제공하고 자가진단을 통해 상태를 점검할 수 있으며, 다양한 치료법을 제공하여 공황장애 케어를 효과적으로 돕는다. 또한, 사용자 실시간 위치를 기반으로 하여 공황을 일으킨 경험이 있는 장소에 도달할 시 알림을 제공함으로써 개인맞춤형 지원을 제공한다. 본 연구에서 개발된 디지털 치료제를 통해 전통적 치료법에서 벗어난 새로운 도구와 치료법을 제시하고자 한다. 더 나아가 공황장애 뿐만 아니라 정신건강 전 분야에서 디지털 치료제 활용을 도모하며, 사용자들의 삶의 질 향상에 기여할 것으로 기대된다.

• 대한의용생체공학회:의공학회지
• /
• 제44권4호
• /
• pp.264-274
• /
• 2023

Purpose: The objective is to extract insights that can contribute to the formulation of harmonized international policies and support measures for innovative medical devices and management systems. This study aims to propose effective strategies for future medical device innovation and healthcare delivery. Results: It investigates technological advancements, regulatory approval systems, insurance policies, and successful commercialization cases in South Korea, the United States, and the European Union. In 2018, the FDA implemented insurance coverage for Software as a Medical Device (SaMD) and recognized insurance coverage for Digital Therapeutics (DTx). Germany is a country that ensures permanent reimbursement for healthcare applications since 2020, making it the first country to provide legal health insurance coverage for fostering a digital ecosystem. Conclusion: The findings of this research highlight the importance of cultivating a supportive regulatory and environmental framework to facilitate the adoption of innovative medical devices. Continuous support for research and development (R&D) efforts by companies, along with the validation of clinical effectiveness, is crucial.

• 한국멀티미디어학회논문지
• /
• 제25권4호
• /
• pp.640-648
• /
• 2022

Menopausal women have to care for their health. Menopause is a symptom that needs to be managed in the long term, which requires safe and economical treatment even after long term use. This study proposes digital-based exercise therapy. This study also suggests resistance exercise and walking exercise methods according to the proof of previous studies. It provides motivational contents for those who cannot perform regularly. As motivational methods, self-efficacy and narrative-based history methods are accepted. Self-efficacy is improved through voice agents feedback during exercise. Feedback is a type of messages such as encouragement and motivation. The narrative-based history consists of characters of visualization that improves through values, which leveraged by the exercise.